BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chun-Hui Nie, Yue-Lin Zhang, Guan-Hui Zhou, Tan-Yang Zhou, Tong-Yin Zhu, Bao-Quan Wang, Sheng-Qun Chen, Hong-Liang Wang, Zi-Niu Yu, Li Jing, Jun-Hui Sun. Analysis of the efficacy of transcatheter arterial infusion chemotherapy in the treatment of pancreatic carcinomaJournal of Interventional Medicine 2020;  doi: 10.1016/j.jimed.2020.10.005
2
Jaeyun Jung, Cue Hyunkyu Lee, Hyang Sook Seol, Yeon Sook Choi, Eunji Kim, Eun Ji Lee, Je-Keun Rhee, Shree Ram Singh, Eun Sung Jun, Buhm Han, Seung Mo Hong, Song Cheol Kim, Suhwan Chang. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous natureOncotarget 2016; 7(38): 62533 doi: 10.18632/oncotarget.11530
3
Jesse M. Mast, Dan Tse, Kevin Shee, M. Lakshmi Kuppusamy, Maciej M. Kmiec, Tamás Kálai, Periannan Kuppusamy. Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer CellsCell Biochemistry and Biophysics 2019; 77(2): 109 doi: 10.1007/s12013-019-00873-6
4
Ugo Soffientini, Annette Graham. Intracellular cholesterol transport proteins: roles in health and diseaseClinical Science 2016; 130(21): 1843 doi: 10.1042/CS20160339
5
Fan Lei, Xinyuan Xi, Surinder K. Batra, Tatiana K. Bronich. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic CancerJournal of Pharmacology and Experimental Therapeutics 2019; 370(3): 682 doi: 10.1124/jpet.118.255786
6
Aesha I. Ali, Amanda J. Oliver, Tinaz Samiei, Jack D. Chan, Michael H. Kershaw, Clare Y. Slaney. Genetic Redirection of T Cells for the Treatment of Pancreatic CancerFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00056
7
Sriram Anbil, Michael Pigula, Huang-Chiao Huang, Srivalleesha Mallidi, Mans Broekgaarden, Yan Baglo, Pushpamali De Silva, Diane M. Simeone, Mari Mino-Kenudson, Edward V. Maytin, Imran Rizvi, Tayyaba Hasan. Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose ChemotherapyMolecular Cancer Therapeutics 2020; 19(6): 1308 doi: 10.1158/1535-7163.MCT-19-0791
8
Dimitrios Moris, Nikolaos Machairas, Diamantis I. Tsilimigras, Anastasia Prodromidou, Aslam Ejaz, Matthew Weiss, Natasha Hasemaki, Evangelos Felekouras, Timothy M. Pawlik. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic CancerAnnals of Surgical Oncology 2019; 26(6): 1657 doi: 10.1245/s10434-019-07261-7
9
Serena Veschi, Laura De Lellis, Rosalba Florio, Paola Lanuti, Alberto Massucci, Nicola Tinari, Michele De Tursi, Pierluigi di Sebastiano, Marco Marchisio, Clara Natoli, Alessandro Cama. Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0904-2
10
Fang Xie, Mei Huang, Xiansheng Lin, Chenhai Liu, Zhen Liu, Futao Meng, Chao Wang, Qiang Huang. The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabineScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26496-0
11
Yanyan Hu, Chongwei Chi, Shunhao Wang, Lingxiong Wang, Ping Liang, Fangyi Liu, Wenting Shang, Weiwei Wang, Fengrong Zhang, Shanshan Li, Heyun Shen, Xiaoling Yu, Huiyu Liu, Jie Tian. A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic CancerAdvanced Materials 2017; 29(33): 1700448 doi: 10.1002/adma.201700448
12
Susanna Hegewisch-Becker, Ali Aldaoud, Thomas Wolf, Beate Krammer-Steiner, Hartmut Linde, Renate Scheiner-Sparna, David Hamm, Martina Jänicke, Norbert Marschner. Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinomaInternational Journal of Cancer 2019; 144(5): 981 doi: 10.1002/ijc.31751
13
Dong S., Wang L., Guo Y. B., Ying H. F., Shen X. H., Meng Z. Q., Chen Hao, Chen Q. W., Li Z. S.. Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort studyWorld Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1175-7
14
Amir Hossein Daneshmanesh, Mohammad Hojjat-Farsangi, Amineh Ghaderi, Ali Moshfegh, Lotta Hansson, Johan Schultz, Jan Vågberg, Styrbjörn Byström, Elisabeth Olsson, Thomas Olin, Anders Österborg, Håkan Mellstedt, Aamir Ahmad. A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibPLOS ONE 2018; 13(6): e0198038 doi: 10.1371/journal.pone.0198038
15
Shiwei Guo, Suizhi Gao, Rendong Liu, Jing Shen, Xiaohan Shi, Sijia Bai, Huan Wang, Kailian Zheng, Zhuo Shao, Chuanyu Liang, Siying Peng, Gang Jin. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancerThe FASEB Journal 2019; 33(1): 873 doi: 10.1096/fj.201800617R
16
Eun A Choi, Yeon-Sook Choi, Eun Ji Lee, Shree Ram Singh, Song Cheol Kim, Suhwan Chang. A pharmacogenomic analysis using L1000CDS2 identifies BX-795 as a potential anticancer drug for primary pancreatic ductal adenocarcinoma cellsCancer Letters 2019; 465: 82 doi: 10.1016/j.canlet.2019.08.002
17
Adriana Harbuzariu, Antonio Rampoldi, Danielle S Daley-Brown, Pierre Candelaria, Tia L Harmon, Crystal C Lipsey, Derrick J Beech, Alexander Quarshie, Gabriela Oprea Ilies, Ruben R Gonzalez-Perez. Leptin-Notch signaling axis is involved in pancreatic cancer progressionOncotarget 2017; 8(5): 7740 doi: 10.18632/oncotarget.13946
18
A. V. Kozlov, D. A. Granov, P. G. Tarazov, A. V. Pavlovskiy, L. I. Korytova, A. A. Polikarpov, S. A. Popov, E. V. Rozengauz. Intra-arterial chemotherapy for advanced pancreatic cancerAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(3): 73 doi: 10.16931/1995-5464.2019373-86
19
Gertrud Forika, Andrea Balogh, Tamas Vancsik, Attila Zalatnai, Gabor Petovari, Zoltan Benyo, Tibor Krenacs. Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In VitroInternational Journal of Molecular Sciences 2020; 21(14): 5100 doi: 10.3390/ijms21145100
20
P. G. Tarazov, A. V. Kozlov, D. A. Granov, A. V. Pavlovskiy, A. A. Polikarpov, E. V. Rozengaus, S. A. Popov, E. V. Vlasova, V. E. Moiseenko. ARTERIAL CHEMOINFUSION IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC PANCREAS CANCERGrekov's Bulletin of Surgery 2016; 175(5): 36 doi: 10.24884/0042-4625-2016-175-5-36-40
21
Feifan Zhou, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Mark L. Lang, Min Li, Wei R. Chen. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor VaccineClinical Cancer Research 2018; 24(21): 5335 doi: 10.1158/1078-0432.CCR-18-1126
22
John P. Neoptolemos, Jörg Kleeff, Patrick Michl, Eithne Costello, William Greenhalf, Daniel H. Palmer. Therapeutic developments in pancreatic cancer: current and future perspectivesNature Reviews Gastroenterology & Hepatology 2018; 15(6): 333 doi: 10.1038/s41575-018-0005-x
23
Randy Yeh, Jonathan Steinman, Lyndon Luk, Michael D. Kluger, Elizabeth M. Hecht. Imaging of pancreatic cancer: what the surgeon wants to knowClinical Imaging 2017; 42: 203 doi: 10.1016/j.clinimag.2016.10.002
24
Diamantis I. Tsilimigras, Dimitrios Moris, Timothy M. Pawlik. ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic CancerAnnals of Surgical Oncology 2019; 26(S3): 610 doi: 10.1245/s10434-019-07436-2
25
Ching-Yao Yang, Ming Huei Fan, Carol H. Miao, Yi Jen Liao, Ray-Hwang Yuan, Chao Lien Liu. Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic CancerMolecular Therapy - Oncolytics 2020; 17: 571 doi: 10.1016/j.omto.2020.05.009
26
Karin Juliane Pelizzaro Rocha-Brito, Emanuella Maria Barreto Fonseca, Breno Germano de Freitas Oliveira, Ângelo de Fátima, Carmen Veríssima Ferreira-Halder. Calix[6]arene diminishes receptor tyrosine kinase lifespan in pancreatic cancer cells and inhibits their migration and invasion efficiencyBioorganic Chemistry 2020; 100: 103881 doi: 10.1016/j.bioorg.2020.103881
27
Shui-Fang Jin, Zhao-Kun Fan, Lei Pan, Li-Ming Jin. Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trialsHepatobiliary & Pancreatic Diseases International 2017; 16(3): 236 doi: 10.1016/S1499-3872(17)60022-5
28
Ganji Purnachandra Nagaraju, Katerina M. Zakka, Jerome C. Landry, Walid L. Shaib, Gregory B. Lesinski, Bassel F. El‐Rayes. Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancerInternational Journal of Cancer 2019; 145(6): 1529 doi: 10.1002/ijc.32227
29
Hongchao Han, Lisheng Wang, Jie Xu, Aikun Wang. miR‑128 induces pancreas cancer cell apoptosis by targeting MDM4Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6047
30
Zhe Pei, Wei Fu, Gongping Wang. A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signalingBiochemical and Biophysical Research Communications 2017; 493(1): 455 doi: 10.1016/j.bbrc.2017.08.170
31
Avital Lev, Amriti R. Lulla, Jessica Wagner, Marie D. Ralff, Joshua B. Kiehl, Yan Zhou, Cyril H. Benes, Varun V. Prabhu, Wolfgang Oster, Igor Astsaturov, David T. Dicker, Wafik S. El-Deiry. Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIPOncotarget 2017; 8(47): 81776 doi: 10.18632/oncotarget.20819
32
Metin Uz, Manisha Kalaga, Ramesh Pothuraju, Juhyung Ju, Wade M. Junker, Surinder K. Batra, Surya Mallapragada, Satyanarayana Rachagani. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancerJournal of Controlled Release 2019; 294: 237 doi: 10.1016/j.jconrel.2018.12.031
33
Serena Veschi, Maurizio Ronci, Paola Lanuti, Laura De Lellis, Rosalba Florio, Giuseppina Bologna, Luca Scotti, Erminia Carletti, Federica Brugnoli, Maria Cristina Di Bella, Valeria Bertagnolo, Marco Marchisio, Alessandro Cama. Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cellsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59492-4
34
Arndt Vogel, Fortunato Ciardiello, Richard A. Hubner, Jean-Frédéric Blanc, Alfredo Carrato, Yoojung Yang, Dipen A. Patel, Varun Ektare, Floris A. de Jong, Sharlene Gill. Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimensCancer Treatment Reviews 2016; 50: 142 doi: 10.1016/j.ctrv.2016.09.001
35
Yunpeng Sun, Qiandong Zhu, Mengtao Zhou, Wenjun Yang, Hongqi Shi, Yunfeng Shan, Qiyu Zhang, Fuxiang Yu. Restoration of miRNA‑148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β‑catenin signaling pathway via downregulating maternally expressed gene‑3Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.7026
36
Claire Vennin, Nicola Rath, Marina Pajic, Michael F. Olson, Paul Timpson. Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapySmall GTPases 2020; 11(1): 45 doi: 10.1080/21541248.2017.1345712
37
Callum Baird Nattress, Gunnel Halldén. Advances in oncolytic adenovirus therapy for pancreatic cancerCancer Letters 2018; 434: 56 doi: 10.1016/j.canlet.2018.07.006
38
Kai Qu, Xing Zhang, Ting Lin, Tian Liu, Zhixin Wang, Sushun Liu, Lei Zhou, Jichao Wei, Hulin Chang, Ke Li, Zheng Wang, Chang Liu, Zheng Wu. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validationScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01904-z
39
Shasha Bi, Yan Wang, Hu Feng, Qingchang Li. Long noncoding RNA LINC00657 enhances the malignancy of pancreatic ductal adenocarcinoma by acting as a competing endogenous RNA on microRNA-433 to increase PAK4 expressionCell Cycle 2020; 19(7): 801 doi: 10.1080/15384101.2020.1731645
40
Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Takafumi Akasu, Masayuki Saruta, Masato Okamoto, Hiroaki Kitamura, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Haruo Sugiyama, Shigeo Koido. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic CancerCancer Investigation 2019; 37(9): 463 doi: 10.1080/07357907.2019.1661427
41
Xiaolong Wei, Jiekun Yang, Sara J. Adair, Harun Ozturk, Cem Kuscu, Kyung Yong Lee, William J. Kane, Patrick E. O’Hara, Denis Liu, Yusuf Mert Demirlenk, Alaa Hamdi Habieb, Ebru Yilmaz, Anindya Dutta, Todd W. Bauer, Mazhar Adli. Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cellsProceedings of the National Academy of Sciences 2020; 117(45): 28068 doi: 10.1073/pnas.2009899117